Precision Medicine

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

Precision Medicine
Jun 10, 2024, 04:49 | Blog
Ibrahim Halil Sahin: I discussed the findings of neoadjuvant rectal cancer study of Dostarlimab with Alison Kanski
Ibrahim Halil Sahin Assistant Professor of Medicine Division of Hematology/Oncology at University of Pittsburgh School of…
Jun 9, 2024, 09:45 | Societies
Chandler Park: A fun discussion at ASCO24 with David O’Malley
Chandler Park recently shared on X: "Dr. David O’Malley and I have a fun discussion…
Jun 7, 2024, 10:04 | Insight
Jacob Adashek: Tissue is not the issue
Jacob Adashek recently shared a post by the National Cancer Institute (NCI) on Linkedin, adding:…
Jun 6, 2024, 06:30 | Blog
Ahmad Tarhini: Chatting with Patrick Hwu about the latest advances in melanoma management
Ahmad Tarhini, Director, Cutaneous Clinical and Translational Research at Moffitt Cancer Center and Research Institute,…
Jun 5, 2024, 10:12 | Societies
Samin Saeed: My first time at ASCO
Samin Saeed, Chief Medical Officer at Random42 Scientific Communication, shared a post on LinkedIn: "At…
Jun 3, 2024, 22:34 | Blog
Daniel Sumarriva: Finally had a chance to meet Sanjay Juneja in person here at ASCO24
Sanjay Juneja, Editorial Board Member at AI in Precision Oncology, shared a post by Daniel Sumarriva, Senior…
Jun 1, 2024, 14:46 | Societies
15 Posts From ASCO24 Day 1 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
May 28, 2024, 05:12 | Blog
Through the NAVIGATE program, veterans will get easier access to promising new cancer treatments - NCI
National Cancer Institute (NCI) shared the following on LinkedIn: “A partnership between the National Cancer…
May 26, 2024, 08:19 | Insight
Andrei Nikiforchin: Our SENTRY trial is finally out
Andrei Nikiforchin, Surgical Oncology Researcher, Expert Consultant of the Online Help Desk for Cancer Patients…
May 23, 2024, 12:31 | Blog
Join four top experts to discuss Post-AACR Spatial Biology Trench and Decoding Cancer Insights - Akoya Biosciences
Akoya Biosciences shared a post on LinkedIn: “How is spatial biology influencing the trajectory of…
May 22, 2024, 11:01 | Blog
Josh Atkins: Identifying Proteomic Risk Factors
Josh Atkins, Senior Cancer Genomic Epidemiologist at the Nuffield Department of Population Health of Oxford…
May 22, 2024, 09:09 | Blog
Paolo Tarantino: Mark your calendars for PER’s 6th Annual Precision Medicine Symposium
Paolo Tarantino made the following post on X: “Mark your calendars for PER’s 6th Annual Precision…
May 20, 2024, 14:34 | Blog
Evolving Concepts in Meningioma Management in the Era of Genomics - ACS Journal Cancer
ACS Journal Cancer shared the following on X: "This new review article from Mass General…
May 20, 2024, 00:34 | Insight
Douglas Flora: Post-AACR Spatial Biology Trends and Decoding Cancer Insights
Douglas Flora shared a post on LinkedIn: “Fireside Chat: Post-AACR Spatial Biology Trends and Decoding Cancer…
May 15, 2024, 09:25 | Blog
Christos Tsagkaris: From tobacco control to precision medicine and citizenship
Christos Tsagkaris, Social Media Editor at JBI Evidence Implementation, shared a post on LinkedIn: "Last but…
May 14, 2024, 12:51 | Blog
Vivek Subbiah: About time for precision immunotherapy
Vivek Subbiah shared a post on LinkedIn: “Sharing our editorial: Rationalizing rules for immunotherapy combination trials:…
May 14, 2024, 09:19 | Blog
Vivek Subbiah: Picking that needle in haystack --> ROS1 fusion in Glioblastoma
Quoting Vivek Subbiah on X: “Picking that needle in haystack --> ROS1 fusion in Glioblastoma. Striking response…
May 14, 2024, 07:15 | Blog
Andrea Necchi: Optimizing the use of NGS in pts with urothelial carcinoma
Andrea Necchi, Associate Professor at Vita-Salute San Raffaele University, shared on X: “Optimizing the use…
May 11, 2024, 11:32 | Blog
Vivek Subbiah: Future of early-phase drug development and precision medicine is bright at Gustave Roussy Cancer Center!
Vivek Subbiah shared a post by Adrien Mouren, on X and added: "Future of early-phase…
May 9, 2024, 16:48 | Blog
Estela Rodriguez: At the heart of every conference there is a director of the orchestra
Carmen Calfa, Breast Oncologist at Sylvester Comprehensive Cancer Center, shared a post by Estela Rodriguez on…
May 7, 2024, 15:35 | Insight
Arndt Vogel: Excellent summary on precision medicine in HCC
Arndt Vogel shared on X: "Precision treatment in advanced HCC. Excellent summary on precision medicine…
May 7, 2024, 15:28 | Blog
Estela Rodriguez: Sylvester Comprehensive Cancer Center discusses nutrition and exercise interventions for cancer management
Estela Rodriguez shared on X/Twitter: "Sylvester Comprehensive Cancer Center discusses nutrition and exercise interventions for cancer…
May 7, 2024, 13:00 | Insight
Carmen Calfa: Let’s keep our fingers on the pulse - QOL and PROs matter!
Carmen Calfa, Medical Director of Clinical Operations and Breast Oncologist at Sylvester Comprehensive Cancer Centre,…
May 7, 2024, 11:33 | Blog
Douglas Flora: The research you’ve performed, and published is changing the way cancer patients are treated around the world
Douglas Flora shared a post by Jaime Grund, Director of St. Elizabeth Healthcare, on LinkedIn: "Patients are safer…
May 4, 2024, 11:45 | Blog
Trish Boh: St. Elizabeth Healthcare’s Precision Medicine Pharmacogenomic Team won the Innovation in Oncology Award
Trish Boh, Directors at St. Elizabeth Healthcare, shared on LinkedIn: "We’re so proud! In March,…
May 3, 2024, 17:25 | Cancer Types
Susanna F. Greer: Planting a new seed for breast cancer research
Susanna F. Greer, Chief Scientific Officer at the V Foundation, published the following newsletter on…
May 2, 2024, 23:45 | Insight
Aakash Desai: Insights into mNSCLC Management through a Global Clinician Survey
Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared a post on…
May 2, 2024, 23:11 | Blog
Vivek Subbiah: My first time inside Gustave Roussey in Paris France
Vivek Subbiah shared a post on LinkedIn: “My first time inside Gustave Roussey in Paris France.…
May 1, 2024, 20:07 | Blog
Vivek Subbiah: Looking forward to delivering the keynote at the esteemed PRISM center in Paris
Vivek Subbiah shared a post on LinkedIn: “Just landed in Paris! Looking forward to delivering…
May 1, 2024, 19:47 | Blog
Donnie Rizzo: A major leap forward in the field of Digital Pathology and AI
Donnie Rizzo, Global Director at Pathology and Oncology at Quest Diagnostics, made the following post…
Apr 30, 2024, 12:48 | Insight
CAGLA's Marc Matrana won the very prestigious Ochsner Academic award
Marc Matrana, System Director of Precision Medicine, shared a post by Cancer Advocacy Group of…
Apr 29, 2024, 15:30 | Insight
Nicola Ferrari: Principles and therapeutic applications of adaptive immunity
Nicola Ferrari, Translational Science Lead at AstraZeneca, made the following post on LinkedIn: "Principles and…
Apr 27, 2024, 11:47 | Blog
Dive deep into the world of lung cancer biomarker testing with Bruna Pellini and Semir Vranić - Precision Oncology CONNECT
Precision Oncology CONNECT shared a post on LinkedIn: “Dive deep into the world of lung…
Apr 26, 2024, 12:00 | Blog
Vivek Subbiah: Window of opportunity (WOO) studies across cancer subtypes by Barbara Pistilli
Vivek Subbiah shared a post on X/Twitter: "Window of opportunity (WOO) studies across cancer subtypes?…
Apr 25, 2024, 20:18 | Positive
Vivek Subbiah: HUGE MILESTONE in all of medicine and a huge win for patients and families with sickle cell disease and β-Thalassemia
Quoting Vivek Subbiah's post on X/Twitter: "Hot off the press! HUGE MILESTONE in all of…
Apr 24, 2024, 14:51 | Blog
Jemma Arakelyan: Just completed the ESMO Advanced Course on lung cancer
Jemma Arakelyan, CEO at the Institute of Cancer and Crisis, shared a post on LinkedIn: "Just…
Apr 23, 2024, 20:22 | Blog
Chandler Park: What a FUN precision medicine and immunotherapy meeting at Cleveland Clinic
Chandler Park, Kentucky Physician Representative of the ASCO State Executive Council, shared on LinkedIn: "What a…
Apr 23, 2024, 18:57 | Insight
New Paper Alert! Identifying a New EGFR Germline Mutation in Lung Adenocarcinoma: A Case Report and Review of the Literature
Identifying a New EGFR Germline Mutation in Lung Adenocarcinoma: A Case Report and Review of…
Apr 23, 2024, 12:12 | Societies
Vivek Subbiah: Fantastic overview of Molecular Tumor Boards - MTB 101 and in-depth thought-provoking lecture by the amazing Ben Westphalen
Vivek Subbiah shared a post on X: "Fantastic overview of Molecular Tumor Boards - MTB…
Apr 23, 2024, 11:34 | Blog
Vivek Subbiah: What a beautiful venue for a terrific meeting - the Italian Summit of Precision Oncology
Vivek Subbiah shared a post on X: "American Academy of Rome! What a beautiful venue…
Apr 22, 2024, 17:53 | Insight
Andrei Nikiforchin: Our SENTRY trial results are now published in Clinical Oncology
Andrei Nikiforchin, Surgical Oncology Researcher at Mercy Medical Center, Baltimore, shared a post on LinkedIn: “What…
Apr 21, 2024, 10:09 | Blog
Arun Azad: Pleased to share our latest work published in Urologic Oncology focusing on precision medicine in prostate cancer
Arun Azad, Consultant Medical Oncologist at Peter MacCallum Cancer Centre, shared on X/Twitter: ''Pleased to…
Apr 17, 2024, 17:23 | Blog
Vivek Subbiah: Should we consider them 2nd generation PARP inhibitors or a completely NEW class of drugs?
Vivek Subbiah shared a post on X: "More than a dozen PARP1 selective drugs in different…
Apr 13, 2024, 09:17 | Societies
30 Posts Not To Miss From AACR24!
The AACR Annual Meeting 2024 was held from April 5th to 10th in San Diego,…
Apr 12, 2024, 16:21 | Societies
Vivek Subbiah: Where does the AACR24 Plenary Chair work with the ASCO Plenary Chair?
Vivek Subbiah shared a post on LinkedIn: "Where does the American Association for Cancer Research AACR24 Plenary…
Apr 11, 2024, 17:43 | Societies
Mark your calendars for our upcoming virtual Grand Rounds to explore the use of Precision Medicine through the TAPUR Study - ASCO
American Society of Clinical Oncology (ASCO) shared a post LinkedIn: “Mark your calendars for our…
Apr 10, 2024, 08:53 | Insight
Vivek Subbiah: Cell atlas projects have contributed to our understanding of cancers
Vivek Subbiah shared on X/Twitter: "We have learned a lot from cell atlas projects -…
Apr 8, 2024, 07:42 | Insight
Pashtoon Kasi: Wondered how it looks when your own immune cells kill cancer?
Quoting Pashtoon Kasi, Director of Colon Cancer Research and Precision Medicine Research for Liquid Biopsies…
Apr 5, 2024, 16:38 | Insight
Roberto Leon-Ferre: The role of immune activation on the prognosis of early TNBC if chemotherapy is not given
Roberto Leon-Ferre, Medical Oncologist at Mayo Clinic, shared on their X/Twitter: ''What is the role…
Apr 5, 2024, 08:35 | Insight
Bishal Gyawali: Why 'number of cancer drugs approved' is a poor surrogate for measuring policy success
Alvaro Carrascal, Assistant Professor at University at Albany School of Public Health, shared a post…
Apr 5, 2024, 02:08 | Blog
Vivek Subbiah: A real-life superhero
Vivek Subbiah shared on LinkedIn: “Want to meet a real-life superhero? Such a delight meeting Mike,…
Apr 3, 2024, 19:25 | Career
Bishoy Faltas: Thrilled to take on this new role as Chief Research Officer of the Englander Institute for Precision Medicine
Bishoy Faltas, Chief Research Officer at Englander Institute for Precision Medicine, shared a post by…
Apr 2, 2024, 12:50 | Blog
Antonio Passaro: Key milestones in cancer biomarker research and future avenues for enhancing the management of patients with solid tumors
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared a post on LinkedIn:…
Mar 31, 2024, 14:23 | Blog
Dana-Farber Cancer Institute: Five Dana-Farber scientists have been chosen to receive Wong Family Awards in Translational Oncology for fiscal year 2024
Dana-Farber Cancer Institute posted on LinkedIn: "Five Dana-Farber scientists have been chosen to receive Wong…
Mar 24, 2024, 13:47 | Career
Jean-Charles Soria: Thank you to my American Association for Cancer Research colleagues for this humbling vote of confidence
Jean-Charles Soria, SVP and Oncology Therapeutic Area Head, shared Amgen Oncology's post on LinkedIn and…
Mar 20, 2024, 16:11 | Blog
On March 21st let's talk about Anal Cancer
Anal Cancer Awareness Day Anal cancer is one of the less discussed cancer types. It…
Mar 20, 2024, 14:34 | Blog
Dive into the world of Precision Medicine this Myeloma and Colorectal Cancer Awareness Month - FDA Oncology
Quoting FDA Oncology on X: "Dive into the world of Precision Medicine this Myeloma and…
Mar 18, 2024, 22:51 | Blog
Learn how we're transforming cancer care by bringing the right treatments to the right patient at the right time - MCW Cancer Center
MCW Cancer Center made the following post on X: 'Our physicians are leaders in Innovation…
Mar 18, 2024, 10:20 | Blog
Zephyr AI Secures $111M In Series A To Advance Precision Medicine - Slice of Healthcare
Quoting Slice of Healthcare on LinkedIn: "Zephyr AI Secures $111M In Series A To Advance…
Mar 10, 2024, 21:03 | Blog
Vivek Subbiah: Research should be standard-of-care and standard-of-care should be research
Vivek Subbiah recently posted on LinkedIn: "Yes! “Research should be standard-of-care and standard-of-care should be research”!!!…
Mar 5, 2024, 16:04 | Blog
Pashtoon Kasi leads the peer ranked "Top 10 Voices in GI Oncology on X" by LARVOL
LARVOL/X recently shared the results of peer survey on "Top Voices in GI Oncology on…
Mar 3, 2024, 17:30 | Insight
Marlene Thomas: I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders
Marlene Thomas, Head of CGP Portfolio Strategy at Roche, shared on LinkedIn: "I want to…
Feb 19, 2024, 17:17 | Career
Stacie Lindsey: We are thrilled that the ESMO announced that the 2024 TAT Honorary Award is bestowed to Dr. Funda Meric-Bernstam
Stacie Lindsey, CEO of Cholangiocarcinoma Foundation, shared on LinkedIn: "We are thrilled that the ESMO…
Feb 17, 2024, 16:20 | Career
Sunil Verma: Francisco J Peña's project will focus on developing AI-based tools for precision medicine in cancer
Sunil Verma, SVP, Global Head of Oncology at AstraZeneca, shared a post by Mattias Rantalainen on…
Feb 11, 2024, 12:19 | Blog
Benedikt Westphalen: I'm deeply grateful for the opportunity to chair the ESMO Translational Research and Precision Medicine Working
Benedikt Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO, recently posted…
Feb 10, 2024, 19:00 | Insight
Jill Feldman: We must try to be ‘precise’ with dosing so people can LIVE better
Jill Feldman shared on X/Twitter: "Thank you, Associated Press for this story on dosing! No…
Jan 27, 2024, 08:16 | Insight
Stephen Nimer: Another important publication from Sylvester’s multiple myeloma team that will be practice changing!
Stephen Nimer, Director at Sylvester Comprehensive Cancer Center, recently shared a post by Sylvester Comprehensive…
Jan 14, 2024, 18:08 | Blog
Vivek Subbiah: The 1st report from the Cancer Programme of the Genomes 100k project
Vivek Subbiah posted on X/Twitter: "Just out Nature Medicine: The 1st report from the Cancer Programme…
Jan 12, 2024, 10:42 | Insight
Shushan Hovsepyan: Ian Tannock compared inhibiting tumor mutations to tree pruning
Shushan Hovsepyan, a Pediatric Oncologist and Clinical Research Coordinator at the Yeolyan Hematology and Oncology…
Jan 11, 2024, 18:08 | Blog
Vivek Subbiah: Who said only movies come in trilogy?
Vivek Subbiah shared a post on LinkedIn: "Who said only movies come in trilogy? Presenting the…
Jan 7, 2024, 17:56 | Insight
Erman Akkus: Can genetics be used to delay mammogram screening?
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Can genetics be used to…
Jan 7, 2024, 15:37 | Insight
Vivek Subbiah: Kicking off the new year 2024 with a bang!
Vivek Subbiah shared on X: "Kicking off the new year 2024 with a bang!  Thrilled…
Jan 2, 2024, 17:47 | Blog
Lisa Lacasse: Major win for patients across New York
Lisa A. Lacasse, the President of American Cancer Society Cancer Action Network, shared on LinkedIn:…
Dec 30, 2023, 18:19 | Blog
Vivek Subbiah: Delighted to unwrap our small Precision Medicine present
Vivek Subbiah recently shared on LinkedIn: “Exciting Christmas Eve news! Just published in ESMO -…
Dec 29, 2023, 15:35 | Blog
Vivek Subbiah: Tumor-agnostic therapies advance possibilities for Precision Medicine
Vivek Subbiah shared on LinkedIn: ''Tumor-agnostic therapies advance possibilities for Precision Medicine. Genomics are driving…
Dec 25, 2023, 16:45 | Insight
Vivek Subbiah: Pleased to share the work of our amazing RET precision medicine team as we review
Vivek Subbiah shared on LinkedIn: "Hot off the press! Pleased to share the work of…
Dec 20, 2023, 11:26 | Blog
Vivek Subbiah: Excited to join as a panelist in the upcoming STAT statnews event "Cancer's Breakthrough Engine"
Vivek Subbiah shared a post on LinkedIn: "Save the Date! Excited to join as a…
Dec 15, 2023, 15:59 | Insight,Opinion
Vivek Subbiah: Precision Medicine for FGFR in bladder cancer has now arrived
Vivek Subbiah shared on X/Twitter: “Just published Annals of Oncology. Pleased to share our editorial "Unlocking…
Dec 11, 2023, 11:15 | Blog
Vivek Subbiah: Precision Medicine - This is how we eradicate cancer as we know it
Vivek Subbiah shared on X/Twitter: "The best breast cancer clinical trial research strategy team in…
Dec 9, 2023, 17:16 | Insight
Vivek Subbiah: Finding the genomic fusion needles in the haystacks via Liquid Biopsy Precision Medicine
Vivek Subbiah, shared a post by Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine and New…
Dec 4, 2023, 15:31 | Blog
Melvin LK Chua: Our commentary on the state of play of radiomics in Precision Oncology
Melvin LK Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of…
Dec 2, 2023, 16:55 | Insight
William Oh: Better biology and new targeted therapies is driving more benefit for patients, but there is still a long way to go
William Oh, Chief Medical Officer at the Prostate Cancer Foundation (PCF), shared on LinkedIn: "MSK-IMPACT…
Nov 25, 2023, 10:34 | Blog
Katya Losk: Dana-Farber Cancer Institute was honored to participate in the 3rd Joint Symposium on Academic Development held at the First Affiliated Hospital, Sun Yat-sen University in Guangzhou, China
Nov 13, 2023, 19:33 | Blog
Vivek Subbiah: Think Tank on Advancing precision medicine in Rare cancers spearheaded by the amazing Jim Palma and Razelle Kurzrock
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 2, 2023, 00:48 | Blog
Vivek Subbiah: Wow! What an amazing event on “Shaping the future of personalised healthcare for cancer patients”
Vivek Subbiah, posted the following on LinkedIn: "Wow! What an amazing event on 'Shaping the…
Oct 17, 2023, 16:41 | Insight
Christine Lovly: Zenocutuzumab (aka Zeno). This is a great Precision Medicine story!
Quoting Christine Lovly, Ingram Associate Professor of Medicine at Vanderbilt University, on X/Twitter: '' Zenocutuzumab…
Oct 15, 2023, 17:35 | Societies
New webinar series by ESMO on precision medicine recommendations
The European Society for Medical Oncology (ESMO) shared on Twitter: Stay updated with the latest…
Oct 7, 2023, 18:24 | Insight
Corrie Painter: Today, the company where I have been working since inception has emerged from stealth.
Corrie Painter, VP External Research & Partnerships at Precede Biosciences, shared the following post by Precede…
Oct 5, 2023, 17:41 | Blog
Vivek Subbiah: Mark your calendars if you are attending the ESMO MAP23 meeting in Paris, France this week, Oct 4-6.
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the  Sarah Cannon Research Institute, on…
Oct 3, 2023, 18:02 | Insight
Vivek Subbiah: Delighted to publish our editorial. TRKing sarcomas for precision medicine: Seek, and ye shall find! In the American Cancer Society Journal Cancer.
Vivek Subbiah, Chief of Early-Phase Drug Development at the  Sarah Cannon Research Institute, shared on X/Twitter:…
Oct 1, 2023, 16:27 | Blog
Razelle Kurzrock: At the Right Dose.
Quoting Razelle Kurzrock, Chair of Precision Oncology at Moore’s Cancer Centre, on X/Twitter: “At the…
Sep 29, 2023, 19:08 | Blog
Jean-Charles Soria: Precision medicine in oncology is evolving towards high-throughput genomics use.
In a post by Jean-Charles Soria, Senior Vice President of Oncology within Global Development at…
Sep 29, 2023, 19:01 | Insight
Pashtoon Kasi: N-of-1 Precision Medicine: This story is very dear to my heart.
Quoting Pashtoon Kasi, The Director of Colon Cancer Research at Weill Cornell Medicine, on X/Twitter: “N-of-1…
Sep 28, 2023, 20:32 | Blog
Vivek Subbiah: So much enthusiasm for delivering Precision Medicine every where.
Vivek Subbiah, made the following post on LinkedIn: "Delighted to visit Park City, Utah to deliver…
Sep 10, 2023, 17:27 | Career
Heiko Enderling: This week I started my tenure at MD Anderson Cancer Center as a Professor in the Department of Radiation Oncology.
Heiko Enderling, Professor in the Department of Radiation Oncology at MD Anderson Cancer Center, recently…
Sep 9, 2023, 20:25 | Blog
Michael Sullivan: Advanced Paediatric Oncology Course (APOC), Edinburgh May 2024.
Michael Sullivan, Paediatric Oncologist and Neuro-Oncologist in the Children's Cancer Centre, Royal Children's Hospital, Co-Chair…
Sep 8, 2023, 18:58 | Blog
Carolina Bernabe: Join me and top Precision Medicine experts on October 20-21 for the 5th Annual Precision Medicine Symposium!
Quoting Carolina Bernabe, Medical Oncologist at Montefiore Einstein, on Twitter: "Join me and top Precision…
Aug 24, 2023, 17:56 | Insight
Justin Stebbing: Was very lucky to be part of a large team that very extensively reviewed the PAM pathway and its importance in cancer.
Quoting Justin Stebbing, on LinkedIn: "Was very lucky to be part of a large team…
Aug 24, 2023, 02:46 | Societies
Precision Medicine Symposium: join experts in Jersey City on October 20-21! - Physicians' Education Resource/PER.
 Physicians' Education Resource/PER shared on their Twitter page: "The fast-paced nature of this year’s Precision…
Jul 31, 2023, 17:24 | Drugs
Delighted to share our latest paper on "Tumor-agnostic drug development in dMMR/MSI-H solid tumors" just published in Trends in Cancer - Vivek Subbiah
Hot off the press! Weekend Reading.  :arrow: Delighted to share our latest paper on "Tumor-agnostic…
12
All: 200 Posts: 101 - 200
Special Coverage